Jacobson Allan Steven
PTC Therapeutics, Inc. · Director
Jacobson Allan Steven is listed in filings as Director at PTC Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 6, 2026, including sale activity. Recent filings connect the profile to PTC Therapeutics, Inc. (PTCT). The current snapshot covers public activity from Oct 7, 2025 to Jan 6, 2026. Reported amounts are shown as $266.7K to $210.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $292k3.5k shares | SellNov 25, 2025 | $83.38 | $78.52 | |
| $211k2.5k shares | SellNov 25, 2025 | $83.93 | $78.52 | |
| $203k2.5k shares | SellNov 25, 2025 | $82.58 | $78.52 | |
| $187k2.3k shares | SellNov 25, 2025 | $82.63 | $78.52 | |
| $105k1.2k shares | SellNov 25, 2025 | $84.47 | $78.52 | |
| $95k1.1k shares | SellNov 25, 2025 | $84.45 | $78.52 | |
| $60k700 shares | SellNov 25, 2025 | $85.32 | $78.52 | |
| $34k400 shares | SellNov 25, 2025 | $85.24 | $78.52 |